Back

Female patients with coronary artery disease and aortic stenosis undergoing a surgical or interventional treatment in terms of revascularization and valve replacement

26 August 2022 (15:15 - 15:55)
Organised by:
Congress Presentation Part of: Aortic valve intervention 2 Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Max Potratz

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

5 More presentations in this session

Presentation thumbnail
Quantitative angiographic assessment of aortic regurgitation post 11 different types of TAVI devices a multicentre pooled analysis of 2665 valves
Professor O. Soliman (Dublin, IE)
Abstract Slides
Presentation thumbnail
Vascular closure device in TAVI with a dedicated endovascular plug-based device - experience from a high-volume tertiary center
Doctor F. Albuquerque (Carnaxide, PT)
Abstract Slides
Presentation thumbnail
Combined strategy for large-bore arteriotomy closure after transcatheter aortic valve implantation
Doctor M. Sluka (Olomouc, CZ)
Abstract Slides
Presentation thumbnail
Effect of TAVR generation on conduction abnormalities - Is newer always better?
Ms B. Masoudian (Stanford, US)
Abstract Slides
Presentation thumbnail
Peri-procedural, 30-day and 1 year-outcomes in chronic dialysis patients undergoing transcatheter aortic valve implantation
Doctor F. Albuquerque (Carnaxide, PT)
Abstract Slides

Access the full session

Session thumbnail
Aortic valve intervention 2

The Event

Event poster

ESC Congress 2022

26 August 2022 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Aortic regurgitation and stenosis: diagnosis and mode of intervention
thumbnail
Congress Session
Failing valves and beyond
thumbnail
Congress Session
Controversies in heart valve disease: integrating art, science, medicine, and surgery into decision-making

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources